Arthritis care & research · 2026
Patients improve, patterns persist: longitudinal stability of RA joint involvement patterns.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Maarseveen Tjardo, Nagafuchi Yasuo, Lend Kristina, Alemyar Seyam, Glas Herman Kasper, Gröndal Gerdur, Gudbjornsson Bjorn, Haavardsholm Espen A, Petersen Kim Hørslev, Lampa Jon, Hetland Merete Lund, Nordström Dan, Nurmohamed Mike, Østergaard Mikkel, Rudin Anna, Heiberg Marte Schrumpf, Sokka-Isler Tuulikki, Uhlig Till, Dieren Josien Veris-van, van Vollenhoven Ronald, Huizinga Tom, Reinders Marcel Jt, Bergstra Sytske Anne, van den Akker Erik, Knevel Rachel
Аннотация
OBJECTIVE: Rheumatoid arthritis is a heterogeneous disease. Data-driven approaches, from synovial histology to joint involvement patterns (JIPs), have sought to define clinically meaningful subgroups. Whether these subgroups represent stable phenotypes or transient disease states remains unclear. We aimed to develop a novel analytical method to measure longitudinal stability of these subsets.
METHODS: We analyzed two randomized controlled trials, NORD-STAR (NOrdic Rheumatic Diseases Strategy Trials And Registries; n=630), BeSt (Behandel-Strategieën, n=445) and one real-world cohort (Reumazorg Zuidwest Nederland (RZWN), n=252), all treated with DMARDs under a treat-to-target strategy. Patients were assigned to previously defined JIP-subgroups based on shared clinical features. Disease progression was then tracked over one year along the two principal axes of JIP variation: overall severity (oligoarticular vs. polyarticular) and anatomical distribution (hand vs. foot). Longitudinal stability was assessed by measuring how phenotypically similar each patient remained to others sharing their initial joint pattern, quanitified using silhouette-like scores.
RESULTS: Effective treatment led to convergence toward mild disease. Nevertheless, patients sharing similar baseline JIPs maintained clustering together over time significantly more than expected by chance in BeSt (P=0.018-0.038), NORD-STAR (P=0.004-0.017), and RZWN (P<0.001), except for JIP-poly in BeSt and JIP-oligo in NORD-STAR. When stratifying by anatomical region, we found that improvement in foot involvement lagged behind hand involvement across trials.
CONCLUSION: Patients with similar baseline joint involvement patterns maintain phenotypic similarity over time, suggesting JIP subgroups reflect distinct, stable phenotypes rather than transient disease states. Our tool is available to study the longitudinal stability of any subset.
METHODS: We analyzed two randomized controlled trials, NORD-STAR (NOrdic Rheumatic Diseases Strategy Trials And Registries; n=630), BeSt (Behandel-Strategieën, n=445) and one real-world cohort (Reumazorg Zuidwest Nederland (RZWN), n=252), all treated with DMARDs under a treat-to-target strategy. Patients were assigned to previously defined JIP-subgroups based on shared clinical features. Disease progression was then tracked over one year along the two principal axes of JIP variation: overall severity (oligoarticular vs. polyarticular) and anatomical distribution (hand vs. foot). Longitudinal stability was assessed by measuring how phenotypically similar each patient remained to others sharing their initial joint pattern, quanitified using silhouette-like scores.
RESULTS: Effective treatment led to convergence toward mild disease. Nevertheless, patients sharing similar baseline JIPs maintained clustering together over time significantly more than expected by chance in BeSt (P=0.018-0.038), NORD-STAR (P=0.004-0.017), and RZWN (P<0.001), except for JIP-poly in BeSt and JIP-oligo in NORD-STAR. When stratifying by anatomical region, we found that improvement in foot involvement lagged behind hand involvement across trials.
CONCLUSION: Patients with similar baseline joint involvement patterns maintain phenotypic similarity over time, suggesting JIP subgroups reflect distinct, stable phenotypes rather than transient disease states. Our tool is available to study the longitudinal stability of any subset.